Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.
After a brain injury, cells that normally nourish nerves may actually kill them instead, a new NYU study in rodents finds. This “reactive” phenomenon may be the driving factor behind neurodegenerative diseases like glaucoma, a leading cause of blindness.
Researchers seeking to unravel the mysteries of how our amazingly complex brains do what they do, often start with the eye. The retina, the light-sensing tissue at the back of the eye has long been a model for scientists to explore how the brain works.
The molecular changes that lead to Fuchs’ endothelial corneal dystrophy (FECD) occur decades before the disease causes blurry vision and other noticeable symptoms in patients, new research by UT Southwestern scientists shows.
A new study from the George Washington University finds that in some parts of the developing brain, the inhibitory neurons cause excitation rather than suppression of brain activity, which could have implications for the treatment of neonatal seizures.
Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.
Researchers who made a knock-in mouse-model of the genetic disorder retinitis pigmentosa 59, or RP59, found no retinal degeneration or thinning, calling into question the commonly accepted mechanism for RP59.